China Health Technology Group Holding Company Limited

China Health Technology Group Holding Company Limited

HHKEX:1069
0.25
HKD
+0.00
(+1.64%)
42.20MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
36.31
11
8.41
2.65
3.76
17
5.94
3.68
0.51
0.52
4.51
0.6
0.92
- -
Basic EPS, GAAP
-7.87
-7.47
-28.31
-15.64
-11.08
-1.54
-7.55
-26.13
-12.16
-1.45
-0.83
2.52
0.23
- -
Free Cash Flow per Basic Share
1.31
-11.3
-15.17
-7.07
-10.75
1.82
-0.64
-0.77
-0.43
-0.04
1.7
0.36
0.34
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
29.02
29.98
39.33
46.23
61.62
63.68
46.1
19.36
9.37
-23.54
-24.31
0.15
0.46
0.47
Tangible Book Value per Share
29.02
29.98
39.33
46.23
33.53
51.3
42.39
19.36
9.37
-23.54
-24.31
0.15
0.46
0.47
Basic Weighted Avg Shares
3
3
3
4
5
5
9
13
13
13
13
79
98
110
Sales/Revenue/Turnover
92
29
27
10
18
86
51
48
7
7
59
48
90
- -
Operating Margin (%)
-8.03
-35.48
-141.3
-334.96
-108.58
-2.63
-23.54
13.92
-634.76
-173.28
-14.32
-44.1
-9.23
- -
Depreciation Expense
1
1
1
3
11
29
21
3
- -
2
3
5
5
- -
Net Income, GAAP
-20
-20
-90
-60
-52
-8
-65
-340
-158
-19
-11
200
23
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.37
- -
Profit Margin (%)
-21.68
-67.87
-336.56
-590.74
-294.57
-9.04
-127.05
-710.66
-2,377.02
-279.75
-18.39
420.14
25.17
- -
Working Capital
60
71
-10
42
16
88
85
-159
-234
-335
-420
-2
17
10
LT Debt
13
236
103
124
175
354
198
159
124
52
14
116
116
114
Total Equity
74
82
152
199
312
386
601
252
122
-307
-317
13
47
57
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
231.88
17.32
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
236.13
17.73
- -
Return on Common Equity (%)
-25.81
-25.23
-81.42
-36.06
-20.82
-2.22
-13.22
-79.85
-84.67
- -
- -
- -
76.11
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
ST Debt
2
1
- -
LT Borrowings
113
116
114
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
102
102
122
Market Capitalization
28
34
38

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
Total Current Assets
53
60
40
Cash, Cash Equivalents & STI
3
4
3
Accounts Receivable, Net
21
34
24
Inventories
4
1
6
Total Current Liabilities
53
43
30
Payables & Accruals
- -
- -
- -
ST Debt
2
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-13.38%
-48.64%
260.41%
Free Cash Flow
-510.09%
-989.04%
17.28%
Net Income, GAAP
-119.14%
-445%
-88.65%
Sales/Revenue/Turnover
110.23%
150.99%
89.5%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
48
2025
- -
- -
90
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2.52
2025
- -
- -
0.23
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Ka Wai Leung
Full Time Employees
29
Sector
Non-energy minerals
Industry
Forest products
Address
Room 4903, Building A Shenzhen GD China
IPO Date
Oct 12, 2009
Website
caflc.co
Business
China Health Technology Group Holding Company Limited operates as an investment holding enterprise, deeply involved in the management of agricultural and forestry resources. The company's activities span from the cultivation, harvesting, and sale of timber, to dedicated businesses in ginseng, horny goat weed, and an expanding portfolio of health products, with a strategic emphasis on "Big Health" and "Rural Revitalization" in mainland China. Established on October 8, 2009, the firm's principal office is situated in Hong Kong.